Product image of Elocta (Efmoroctocog Alfa) supplied by GNH India

Elocta

Active Ingredient:
Efmoroctocog Alfa
Origin:
EU

Elocta (Efmoroctocog Alfa)

Elocta (Efmorocotocog Alfa) is a recombinant factor VIII therapy for hemophilia A. This intravenous medication is designed to manage bleeding episodes and prevent complications. Learn more about Elocta's uses and effects.

Manufacturer / TM Owner

Swedish Orphan Biovitrum Ab (Publ)

1
Pack/s
This product is added to your enquiry list

Request a Quote

Please fill out the form below and our team will get back to you shortly with pricing and further information.

Indications & Clinical Uses

  • Elocta is primarily used for the treatment and prevention of bleeding episodes in patients with hemophilia A. This condition is characterized by a deficiency in factor VIII, a protein essential for blood clotting. Elocta works by replacing the missing factor VIII, helping to control bleeding and reduce the risk of complications. It is often used as part of a comprehensive treatment plan for hemophilia A.

Side Effects

  • Elocta is designed to help manage bleeding episodes in individuals with hemophilia A. By replacing the missing factor VIII, it aids in the clotting process, which can help control bleeding and reduce the risk of complications. The effects of Elocta can vary depending on the individual and the severity of the condition.

Precautions & Warnings

  • Elocta should be administered under the supervision of a healthcare professional. It is important to follow the prescribed dosage and administration instructions carefully. Patients should be monitored for any signs of allergic reactions or other adverse effects. Elocta should be stored and handled according to the manufacturer's guidelines to ensure its effectiveness and safety.

Avoid Interactions

  • Elocta may interact with other medications or substances. It is important to inform your healthcare provider about all medications, supplements, and herbal products you are taking before starting Elocta. Certain medications, such as those that affect blood clotting, may interact with Elocta and affect its effectiveness. Always consult with a healthcare professional before taking Elocta with other medications.

Frequently Asked Questions

Elocta is used to treat and prevent bleeding episodes in patients with hemophilia A, a condition characterized by a deficiency in factor VIII.

Elocta is administered intravenously, typically under the supervision of a healthcare professional.

Common side effects of Elocta may include allergic reactions, headache, and nausea. Always consult with a healthcare professional for personalized advice.

Elocta may interact with other medications. It is important to inform your healthcare provider about all medications you are taking before starting Elocta.

Elocta should be stored according to the manufacturer's guidelines to ensure its effectiveness and safety. Always follow the storage instructions provided.

Editorial & Trust Signals

Published by

GNH India Pharmaceuticals Limited

Licensed pharmaceutical wholesaler & exporter

Last updated:

References

Disclaimer

At GNH India, we aim to provide information that is expert-reviewed, accurate, and reliable. However, all content on this platform is intended for general informational purposes only and does not constitute professional medical advice, diagnosis, or treatment. While efforts are made to maintain accuracy and currency, the information may contain errors, omissions, or may not reflect the latest developments. Always consult a qualified healthcare professional regarding any medical concerns.

All product names, brand names, trademarks and registered trademarks displayed on this website are the property of their respective owners. This website and its operator are not affiliated with, endorsed by, or authorized by any such trade mark owners unless expressly stated. Any reference to product names or trademarks is made solely for descriptive and informational purposes. No commercial relationship, sponsorship, approval, or association with any trademark owner should be inferred. Information provided herein does not constitute promotion, advertising, or an offer for sale of any medicinal product and is intended solely for general informational purposes.

All trademarks and brand names displayed on this website are used strictly in accordance with the provisions of the Trade Marks Act, 1999, specifically Sections 30 and 30(1) governing fair use. Trademark ownership has been accurately attributed under the "Manufacturer/ TM Owner" section in compliance with statutory requirements.

Related Products

Other formulations containing Efmoroctocog Alfa

A

A
A

A
A

A
A

A

Browse all products →

Ordering Process

Simple, Secure, and Seamless

Learn how our streamlined ordering process guarantees fast, compliant, and reliable access to essential medicines worldwide.

Quote request form

01

Submit Quote Request Form

Tell us what medications you need by filling out our simple form and uploading a valid document.

Price estimate review

02

We Review & Send Estimate

Our licensed pharmacists will verify your details and provide you with a detailed cost estimate.

Secure payment

03

Confirm & Make Payment

Discuss any queries, approve the estimate, and complete your payment.

Worldwide delivery

04

Get Delivered

Your medicines, safely packed and delivered to your door or nearest airport — hassle-free.

Regulatory recognitions

Quality You Can Trust

Our internationally recognized certifications underscore our commitment to safety, quality, and excellence.

SGS GSDP Certification

GSDP Compliant from SGS

URS ISO 9001

URS ISO 9001 Certification

FDA Maharashtra

Licensed by FDA Maharashtra

IEC License DGFT

IEC License issued by DGFT